Ivy Brain Tumor Center

Academic/Hospital

Also known as: Chief Scientific Officer/Director of the Ivy Brain Tumor Center | Deputy Director of the Ivy Brain Tumor Center | Ivy Brain Tumor Center | Ivy Center for Advanced Brain Tumor Treatment

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Dec 21, 2018

Last known activity

Jan 31, 2026

Timeline

No events for the selected filters.

Drugs by trial phase (14 distinct, 12 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

abemaciclib

Phase 1 (11 own, 0 via acquisition)

Indications

Studied for

Recent trials (17)

NCT07268053OfficialEarly Phase 1Jan 31, 2026
NCT06883747OfficialEarly Phase 1Apr 28, 2025
NCT06388733Lead sponsorPhase 3Jun 19, 2024
NCT06388733OfficialPhase 3Jun 19, 2024
NCT06072586Overall official - principal investigatorEarly Phase 1Oct 18, 2023
NCT06072586CollaboratorEarly Phase 1Oct 18, 2023
NCT05940493CollaboratorPhase 2Oct 15, 2023
NCT05940493Overall official - principal investigatorPhase 2Oct 15, 2023
NCT05773326CollaboratorEarly Phase 1May 15, 2023
NCT05182905CollaboratorEarly Phase 1Mar 9, 2022
NCT05076513Overall official - principal investigatorEarly Phase 1Oct 31, 2021
NCT05076513CollaboratorEarly Phase 1Oct 31, 2021
NCT04614909CollaboratorEarly Phase 1Dec 31, 2020
NCT04424966CollaboratorEarly Phase 1Jun 1, 2020
NCT04391595CollaboratorEarly Phase 1May 31, 2020

Details

Last known activity: Jan 31, 2026